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ABSTRACT
Background and Objectives: Elective laparoscopic cho-
lecystectomy has a low risk for infectious complications,
but many surgeons still use prophylactic antibiotics. The
aim of this prospective study was to investigate the ne-
cessity and test the efficacy of prophylactic antibiotics on
postoperative infection complications in low-risk patients
undergoing laparoscopic cholecystectomy.
Methods: Low-risk patients were randomly placed into 2
groups: 68 patients (group 1) received cefazolin 1g intra-
venously after induction of anesthesia, and 76 patients
(group 2) were not given prophylactic antibiotics. In both
groups, septic complications were recorded and com-
pared.
Results: Positive bile culture and gallbladder rupture did
not significantly increase the rate of surgical site infec-
tions. In group 1, there were 3 (4.41%) cases of wound
infection, 3 (4.41%) cases of pulmonary infections, and 1
(1.47%) case of urinary tract infection. In group 2, there
were 2 (2.63%) cases of wound infection, 2 (2.63%) case
of pulmonary infections, and 3 (3.95%) cases of urinary
tract infection. No significant difference existed in the
complication rates.
Conclusions: Based on our data, the use of prophylactic
antibiotics does not decrease the rate of postoperative
infection complications and surgical-site infections and is
not necessary in low-risk patients undergoing laparo-
scopic cholecystectomy.
Key Words: Laparoscopic cholecystectomy, Surgical site
infection, Prophylactic antibiotics, Endobag extraction.
INTRODUCTION
Surgical site infections (SSIs), a significant postoperative
complication, can lead to considerable patient morbidity and
mortality.1 Preventing postoperative infection is an essential
factor in improving the results of surgical procedures. One
approach to preventing infection is the administration of
prophylactic antibiotics. The benefits of preoperative antibi-
otics, which reduce bacterial contamination during clean-
contaminated operations such as cholecystectomy and con-
taminated operations, are well known.1–3
At present, laparoscopic cholecystectomy (LC) is the
standard treatment for symptomatic cholelithiasis. The
incidence of infectious complications after LC is signif-
icantly lower compared with infections with open cho-
lecystectomy.4,5 The use of prophylactic antibiotics as a
means of preventing SSIs is still controversial in elective
LC, which has a low risk for infectious complications.
Many authors believe that antibiotic prophylaxis may
not be necessary in low-risk patients undergoing elec-
tive LC.6–10 On the contrary, many other surgeons still
use and recommend the administration of prophylactic
antibiotics.11–15 McGuckin et al16 documented in their
chart review that 79% of patients who had undergone
LC were given prophylactic antibiotics preoperatively.
Because of its broad-spectrum antimicrobial effect, low
toxicity, and low cost, the single-dose use of cefazolin has
been recommended for patients undergoing open chole-
cystectomy and other biliary surgery,2,17 and it was rec-
ommended by the United States Centers for Disease Con-
trol and Prevention as the general principle for prevention
of postoperative surgical site infection (SSI) in open cho-
lecystectomy.3,18
Because controversy still surrounds the routine use of
prophylactic antibiotics in elective LC, this prospective
study was conducted according to the United States Cen-
ters for Disease Control and Prevention guidelines with
the aim of investigating the necessity and testing the
efficacy of single-dose cefazolin as a prophylactic antibi-
otic to prevent postoperative infection complications in
low-risk patients undergoing LC.
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SCIENTIFIC PAPERMATERIALS AND METHODS
A double-blind, prospective, randomized, controlled
study comparing the prophylactic use of cefazolin (Group
1) vs placebo (group 2) was performed between January
1, 2005 and December 31, 2007 in our clinic. In all, 343
LCs were performed in this period. Following Institutional
Research Ethics Committee approval of the protocol, 150
patients undergoing elective laparoscopic cholecystec-
tomy were selected as suitable for the study protocol. All
patients participating in the study gave informed written
consent. Exclusion criteria were patients older than 60
years; antibiotic intake in the 7 days prior to surgery; acute
cholecystitis in the 6 months prior to the procedure; evi-
dence of cholangitis and/or obstructive jaundice and bil-
iary pancreatitis; regular corticosteroid therapy; preg-
nancy or lactation; previous biliary tract surgery or
previous endoscopic retrograde cholangiopancreatogra-
phy; presence of American Society of Anesthesiologists
classification (ASA) higher than score II; evidence of dia-
betes mellitus; body mass index higher than 30; and con-
version to open cholecystectomy.
Cefazolin (1g) or normal saline was administered intrave-
nously by the anesthesiologist during induction of anes-
thesia. One of 2 packages containing either cefazolin or
placebo was chosen randomly by the anesthesiologist for
each patient. The package was opened by the anesthesi-
ologist, and the type of solution administered (cefazolin
or placebo) was recorded. The medical staff and the pa-
tient were unaware of the content of the solution. After
induction of anesthesia, the skin was disinfected with a
10% solution of povidone-iodine. LC was performed in all
patients by using a 4-trocar technique. A 10-mm trocar
was placed with the open technique using an infraumbili-
cal incision. The other 3 trocars were placed under direct
vision. A 10-mm trocar was placed in the epigastrium, a
5-mm trocar on the midclavicular line, and a 5-mm trocar
in the right flank in line with the gallbladder fundus. If
gallbladder rupture and spill of bile or stones was encoun-
tered, spilled stones were retrieved whenever possible,
and local peritoneal lavage with 1000cc saline was per-
formed. The gallbladder was removed through the umbil-
ical port, always with the use of an endobag that was
prepared using a sterile glove without talc. A drain was
never placed. A sample of bile was removed by suction
with a sterile syringe from the gallbladder immediately
after its removal and sent to the microbiology laboratory
for bacterial detection.
Antithrombotic prophylaxis was not administered, and a
vesical catheter was not inserted. A nasogastric tube was
positioned during the induction of anesthesia and re-
moved at the end of surgery. The postoperative course
was monitored, and any incidents, such as fever, infection
of the trocar site, or intraabdominal collection of pus,
were recorded. After discharge from the hospital, the
patients underwent weekly clinical and laboratory post-
operative monitoring for SSI for a 30-day period.
The following data were collected for each patient: age,
sex, body weight, ASA classification, blood biochemical
data, times of antibiotic administration, time of skin inci-
sion, gallbladder rupture, bile and/or spillage, positive
bile culture, type of fascia and skin closure, duration of
surgery, conversion to open cholecystectomy, bile and
wound culture results, length of hospital stay, and number
of septic complications. Postoperative superficial or deep
incisional soft tissue SSI and intraabdominal abscess (or-
gan/space SSI) were defined according to published cri-
teria.1 If local signs of inflammation or a pus collection
were present, bacteriological swabs were taken from the
wound site.
Statistical analyses were performed using chi-square test,
Fisher’s exact test, and Mann-Whitney U-Test. All analyses
were conducted using SPSS 10 software (SPSS, Inc., Chi-
cago, IL, USA) with a P-value 0.05 considered as signif-
icant.
RESULTS
Six patients (4 patients from group 1 and 2 patients from
group 2) who were converted to open cholecystectomies
were excluded from the original groups. Groups 1 and 2
included 68 and 76 patients, respectively. The character-
istics of the groups and number of infectious complica-
tions are presented in Table 1. No significant differences
existed between the 2 groups regarding sex, age, body
weight, ASA score, conversion to open cholecystectomy,
duration of surgery, number of intraoperative gallbladder
perforations and spill of bile or stones, number of positive
bile cultures, mean postoperative hospital stay, or number
of infectious complications. Group 1 had 3 (4.41%) super-
ficial SSIs in the umbilical port site, 3 (4.41%) pulmonary
infections, and 1 (1.47%) urinary tract infections, for an
overall infection rate of 10.29%. Group 2 had 2 (2.63%)
superficial SSIs in the umbilical port site, 2 (2.63%) pul-
monary infections, and 3 (3.95%) urinary tract infections,
for an overall infection rate of 9.21%. There was no sig-
nificant association between intraoperative gallbladder
rupture or positive bile culture and SSI. The rate of gall-
bladder rupture in groups 1 and 2 were 13.2% and 15.79%,
respectively. SSI occurred in 1 of 21 patients who had a
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ture (P0.05). The positive culture rates of bile in patients
in groups 1 and 2 were 13.2% and 17.1%, respectively, and
the difference was not significant. The most commonly
isolated microorganisms are summarized in Table 2. SSI
occurred in 1 of 22 patients who had a positive bile culture
and in 4 of 122 patients who had a negative bile culture
(P0.05). Wound culture was negative in 2 of 4 patients
who had negative bile culture and in the 1 patient who
had a positive bile culture. In the other 2 of 4 patients who
had a negative bile culture, coagulase-negative Staphylo-
coccus spp. and Staphylococcus aureus were isolated on
pus culture from the wounds. SSI was treated in all pa-
tients by pus drainage.
DISCUSSION
The average rate of SSIs for LC has been reported in the
literature to be between 0.4% and 6.3%,6–8,10,13,16,19 which
is lower than rates reported for open cholecystectomy.4,5
Our data show that the incidence of SSI in patients was
3.47% for the total study group, 4.41% for group 1, and
2.63% for group 2, and in agreement with previous stud-
ies, there was no significant difference in infection rate
between the groups. All SSIs were superficial SSIs and
minor complications.
Although antibiotic prophylaxis is considered standard pro-
tocol in open cholecystectomy as a means of reducing the
incidence of infectious complications, its use is still debated
in LC. Lippert and Gastinger11 performed a prospective pop-
ulation-based multicenter study to evaluate antimicrobial
prophylaxis in laparoscopic and conventional cholecystec-
tomy. They recommend that both laparoscopic and conven-
tional open cholecystectomy be performed with adequate
perioperative antimicrobial prophylaxis because patients re-
ceiving prophylaxis fared significantly better than those with
no prophylaxis in terms of the rate of postoperative infec-
tions, other complications, reoperation, and mortality. Simi-
larly, several other studies conclude that the use of prophy-
lactic antibiotics in LC leads to a significant decrease in
infectious complications.12–15 Conversely, many prospective
studies have suggested that antibiotic prophylaxis is proba-
bly not required in elective LC, because the infection rate of
LC is already low and the use of prophylactic antibiotics does
not decrease the incidence of SSIs and other postoperative
infection complications.6–10 Goldfaden and Birkmeyer20 re-
viewed the perioperative treatment of patients with laparo-
scopic interventions in 98 randomized studies on antibiotic
prophylaxis since 1990. They stated that routine antibiotic
use in LC is likely unnecessary for low-risk patients. Catarci et
al19 recommended in their review that a multicenter prospec-
tive randomized controlled clinical trial be designed to find a
definitive answer to the question of routine antibiotic pro-
phylaxis in LC, because there are no randomized trials with
a sufficient number of cases to avoid a type II error. The
theoretical number of patients necessary for such a trial was
estimated to include more than 3500 patients.19
The positive bile culture rate in patients with gallbladder
stones has ranged between 10% and 42.5% in previous
studies.6,7,9,12–14 Perforation during gallbladder surgery is
attributed to traction, grasping, dissection, and removal of
Table 2.
Microorganisms Isolated From Gallbladder Bile
Microorganism Group 1
(n 
68)
Group 2
(n 
76)
Esherichia coli 46
Enterococcus species 33
Klebsiella species 22
Pseudomonas aeruginosa 12
Staphylococcus species 01
Enterobacter aerogenes 01
Monobacterial 8 11
Mixed flora 1 2
Total bile culture  91 3
Table 1.
Characteristics of Patients and Infectious Complications*
Characteristics Group 1
n  68
Group 2
n  76
Sex (M/F) 10/58 12/64
Mean age (y) 44.623.4 42.521.6
Body weight (kg) 73.37.61 74.17.73
ASA score (I/II) 58/10 62/14
Conversion n (%) 4 (5.88) 2 (2.63)
Infected bile n (%) 9 (13.2) 13 (17.1)
Bile or gallstone spillage 9 (13.2) 12 (15.79)
Duration of surgery (min) 7734.2 85.132.2
Length of hospital stay (d) 1.1170.324 1.51180.325
SSI (superficial) n (%) 3 (4.41) 2 (2.63)
Urinary tract infection 1 3
Pulmonary infection 3 2
*P values not significant.
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The effect of positive bacteria culture and bile or stone
spilling due to perioperative gallbladder perforation on
the occurrence of SSI infections is still controversial.
Shindholimath et al13 found that bactibilia was the most
important predictor of wound infection in low-risk pa-
tients undergoing elective LC. They recommended pro-
phylactic antibiotics to reduce the incidence of wound
infection because it might not be possible to determine
which patients have bactibilia by routine investigation.
Uchiyama et al12 reported that preoperative prophylaxis
with 0.5g sulbactam and 0.5g cefoperazone significantly
reduces the positive bile culture, resulting in a significant
reduction in complications induced by postoperative in-
fections. However, Dervisoglou et al14 stated that both
positive bile culture and intraoperative gallbladder rup-
ture were strongly associated with development of SSI.
Additionally, they determined that SSI was caused by
exactly the same pathogens found in intraoperative cul-
tures. In our study, we detected that the overall rate of SSI
did not correlate with the presence of bacteria in the bile
or gallbladder rupture. Many other studies have also in-
dicated that SSIs are not related to bile culture, rupture of
the gallbladder, or spillage of gallbladder stones or
bile.4,6,7,9,10
On the other hand, there was no relationship between the
perioperative organisms isolated from the bile and the
subsequent SSI in our study or in other studies.6,9,21 Tocchi
et al9 in their study identified different microorganisms in
pus culture in 10/11 bile culture positive patients which
had septic complications. However, Harling et al21 de-
tected that all organisms isolated from the wound sites of
patients who developed SSIs were skin commensals. They
did not find a significant difference in rate of SSI between
prophylactic antibiotic usage and mechanical isolation of
the gallbladder with endobag during extraction from the
abdomen. Hamzaoglu et al22 also reported that the um-
bilical flora and the bile were not the source of the SSIs
after laparoscopic surgery. Also in our study, possibly
commensal coagulase-negative Staphylococcus spp were
isolated from 1 of 2 patients with negative bile culture, and
Staphylococcus aureus was isolated from the other patient
in the pus culture. The wound culture was negative in the
other 2 patients with negative and 1 patient with positive
bile cultures. We believe that mechanical isolation of the
gallbladder from the umbilical wound with routine en-
dobag use in all patients while extracting the gallbladder
from the abdomen and local peritoneal irrigation in the
presence of gallbladder perforation is effective in prevent-
ing contamination with possibly infected bile. The prep-
aration of an endobag from gloves without talc is an easily
prepared, effective, and cost-effective method that we
routinely use. In our study, despite prevention of contam-
ination with the endobag of the umbilical port area, the
fact that all SSI infections occurred at the umbilical port
area leads us to believe that entering with the first port
open procedure and extracting the gallbladder from the
umbilical port leads to more tissue trauma than that sus-
tained in the other wounds at the port entrances.
CONCLUSION
Based on our data, perioperative gallbladder perforation
and possible positive bile culture do not increase SSI rates.
Local irrigation in the case of perforation and the mechan-
ical isolation of the gallbladder while extracting it from the
abdomen with an endobag in the case of bactobilia seem
to be adequate to prevent contamination. Antibiotic pro-
phylaxis does not seem to affect the incidence of SSIs and
is not necessary for elective LC in low-risk patients.
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